Senescence-driven osteonecrosis of the femoral head in the elderly—a distinct pathophysiological entity
This article conceptualizes "Senescence-Driven Osteonecrosis of the Femoral Head" in elderly patients as a distinct pathophysiological entity, differing from classic osteonecrosis of the femoral head (ONFH) by its primary age-related etiological factors. It hypothesizes that this condition arises from a convergence of vascular fragility, impaired bone mechanoadaptation, and systemic inflammaging. Epidemiological patterns reveal under-recognition and diagnostic delays, with presentations often mimicking osteoarthritis. The manuscript examines endothelial cell senescence, microvascular dysfunction, increased bone marrow adiposity-reducing perfusion and osteogenic capacity-and chronic inflammation in the aging femoral head. Emerging omics and biomechanical evidence, including subchondral insufficiency fractures, highlight molecular and structural differences contributing to collapse. Conventional joint-preserving treatments often fail in older individuals, prompting exploration of novel therapies like senolytics, vasculoprotective agents, and early mechanical support. This work advocates for a new framework integrating geriatric comorbidities and senescence biology for tailored diagnosis, prevention, and treatment of this debilitating condition.
Authors
- Tianyou Yang (ORCID: https://orcid.org/0000-0001-9140-3806)
- Peng-peng Wen
- Tian-Xin Chen (ORCID: https://orcid.org/0000-0002-9663-6294)
- Yu Zhang
- Ye Luo
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-12-10
- DOI
- https://doi.org/10.3389/fmed.2025.1653037
- Primary Topic
- Bone and Joint Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00